This evidence-based guide examines: The pharmacology and mechanism of GLP-1 receptor agonists Whether delayed gastric emptying affects nutrient absorption How sustained appetite suppression may alter micronutrient density Protein intake and lean mass preservation during rapid weight loss Nutrients of potential concern (iron, vitamin B12, folate, magnesium, calcium, vitamin D, fat-soluble vitamins, electrolytes and zinc) Clinical monitoring strategies and laboratory markers Dietary and supplementation considerations grounded in current evidence Current literature does not support the claim that GLP-1 medications universally cause micronutrient deficiencies
These calculations are for education only and do not replace clinical advice, diagnosis, or treatment
Research in mice suggests that coffee increases the release of GLP-1
the carrier can be any suitable material that can dissolve the active ingredients and co-ingredients
Further compounding the problem is the absence of sufficient patient persistence on the drugs: A relatively large portion of patients discontinue these medications within one year , with numbers increasing by the end of years two and three